To diagnose Attention Deficit Hyperactive Disorder (ADHD) accurately and treat it effectively requires a multidisciplinary, multimodal approach that involves psychosocial and psychopharmacological interventions. Characteristics that one may be observed in persons with ADHD include excessive movement of extremities and inability to sit still for extended periods of time, aggressive behavior and sudden mood swings, and carelessness and absentmindedness that may manifest themselves as inattentiveness in class and contribute to impaired academic performance. There is a significantly higher prevalence of ADHD in boys, who are 1.5 to 5.8 times more likely than girls to be diagnosed. The disorder often has a chronic course with about 70% of affected children presenting threshold symptoms and associated impairments in adolescence and 30 to 50% presenting them in adulthood. To address such concerns and determine the biosafety of such medications, the present study comprises an assessment of the side effects of medications provided by Brazil’s public health service to treat ADHD.
Impact Factor
2022: 6.012
This work is licensed under a